In addition, SETMAR is dysregulated in several cancers, such as glioblastoma, leukemia, hematologic neoplasms, breast and colon cancer, and mantle cell lymphoma [16,22,23,24,25,26,27,28,29,30]. Here, SETMAR is linked to cancer.